Euroscreen
Get Full AccessDescription
- Ogeda is a Belgium-based, privately owned clinical-stage drug discovery company that invents and develops small molecule drug candidates targeting GPCRs. Ogedas orally-available and proprietary lead drug candidate fezolinetant (ESN364) is currently in Phase II clinical development for the treatment of womens health disorders. Ogeda has additional small molecules targeting GPCRs in pre-clinical development in multiple therapeutic areas including inflammatory and autoimmune diseases. Ogeda is backed by leading investors, including Vesalius Biocapital, Fund+ and SRIW. For more information, please visit: www.ogeda.com
-
Headquarters:31 Maplewood Dr , Montgomery, Alabama, United States
More -
Phone Number:
-
Website: https://www.euroscreen.com
-
Employees:22
-
Revenue:$1 - 10M
-
Legal Name:Euroscreen
-
Euroscreen's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Euroscreen
-
Where are Euroscreen's Headquarters?
Euroscreen's Headquarters are in 31 Maplewood Dr ,Montgomery,Alabama,United States
-
What is Euroscreen's official website?
Euroscreen's official website is https://www.euroscreen.com
-
What is Euroscreen's Revenue?
Euroscreen's revenue is $1 - 10M
-
What is Euroscreen's NAICS code?
Euroscreen's NAICS code is 325412
-
How many employees are working in Euroscreen
Euroscreen has 22 employees
-
What is Euroscreen's Industry?
Euroscreen is in the industry of Pharmaceuticals
-
Who is Euroscreen's Director Business Development?
Euroscreen's Director Business Development is Al Gray
-
Who is Euroscreen's Director, Drug Discovery?
Euroscreen's Director, Drug Discovery is Graeme Fraser